Exinity ME Limited (https://nemo.money) is licensed by Abu Dhabi Global Market (ADGM) and regulated by ADGM's Financial Services Regulatory Authority (FSRA) as an Authorised Person to conduct the Regulated Activities of (a) Dealing in Investments as Principal (Matched), (b) Dealing in Investments as Agent, and (c) Arranging Custody, in and from ADGM, with Financial Services Permission No. 200015. Its registered office is 16-104, 16th Floor, Al Khatem Tower, ADGM Square, Al Maryah Island, Abu Dhabi, UAE.

Exinity ME Limited, trading as Nemo, is part of the Exinity Group, which includes but is not limited to:

Exinity UK Limited with registration number 10599136 and registration address at 8-10 Old Jewry, London, England, EC2R 8DN is authorised and regulated by the Financial Conduct Authority with license number 777911.

Exinity Capital East Africa Ltd with registration number PVT-ZQU6JE7 and registration address at West End Towers, Waiyaki Way, 6th Floor, P.O. Box 1896-00606, Nairobi, Republic of Kenya is regulated by the Capital Markets Authority of the Republic of Kenya with a Non-Dealing Online Foreign Exchange Broker with license number 135.

Risk Warning: You should not invest more than you can afford to lose and should ensure that you fully understand the risks involved. It is the responsibility of the client to ascertain whether he/she is permitted to use the services of Exinity ME Ltd based on the legal requirements in his/her country of residence.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Please read Nemo's full Risk Disclosure.

For Q2 2026, 30% of Retail Client accounts that traded or held OTC Leveraged CFDs were profitable. For Q1 2026, 28.7% were profitable. For Q4 2025, 41% were profitable. For Q3 2025, 52% were profitable.

Disclaimer: This written/visual material is compromised by personal opinions and ideas. The content should not be construed as containing any type of investment recommendation and/or a solicitation for any transactions. It does not imply any obligation to purchase investment services, nor does it guarantee or predict future performance. Exinity ME Ltd, its affiliates, agents, directors, officers or employees do not guarantee the accuracy, validity, timeliness or completeness of any information or data made available and assume no liability for any loss arising from any investment based on the same.

Terms & Conditions

Themes Insights Stocks Compare

Themes Insights Stocks Compare

Alpha Tau Medical (DRTS) Stock Forecast 2026: Price Target

ALPHA TAU MEDICAL LTD

Alpha Tau Medical (DRTS) Stock

Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Alpha Tau Medical in October 2026.

Alpha Tau Medical (DRTS) Stock Forecast

Analyst RatingStrong Buy

Analyst price target, next 12 months

$11.89

-7.3% vs today's $12.83

Price range over the last 12 months

Close to its 12-month high

Today $12.83

$3.0052-week low

$14.7552-week high

327.7% above the year's low13.0% below the year's high

Analysts covering Alpha Tau Medical have a consensus 12-month target of $11.89, below the current price of $12.83.

Analyst targets are opinions, not guarantees. Capital at risk. Data as of 23 Oct 2026.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Sixth Month Growth Performance

$12.83

+4.13 (47.47%)past 6 months

Stock Performance Snapshot

Strong Buy

Analyst Rating

Analysts highly recommend buying Alpha Tau Medical’s stock due to strong growth potential.

Average

Financial Health

Alpha Tau Medical is showing reasonable cash flow and book value per share for a young company.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

View more stocks by downloading the app for FREE

It only takes 60 seconds.

Why invest with Nemo?

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

About This Stock

ALPHA TAU MEDICAL LTD

DRTS

Current Price

$12.83

Potential 12 Month Profit

-19.12%

Sector

Financials

Industry

Investment Holding Companies

Ticker

DRTS

Market Cap

$1.37B

Potential 12 Month Profit

-19.12%

Sector

Financials

Industry

Investment Holding Companies

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

हिंदी

Baskets Featuring DRTS

Radiopharma Revolution: Promise Meets Market Risk

Radiopharma Revolution: Promise Meets Market Risk

Aktis Oncology's highly successful and upsized IPO, strongly backed by pharma giant Eli Lilly, signals a surge of investor confidence in radiopharmaceutical cancer therapies. This theme focuses on the companies poised to ride this wave of investment and innovation in one of biotech's most promising frontiers.

Published: 9 January 2026

Compare Alpha Tau Medical with other stocks

Southern First vs Alpha Tau Medical Runway Growth Finance vs Alpha Tau Medical Alpha Tau Medical vs MBIA

Southern First vs Alpha Tau Medical

Southern First vs Alpha Tau Medical

Runway Growth Finance vs Alpha Tau Medical

Runway Growth Finance vs Alpha Tau Medical

Alpha Tau Medical vs MBIA

Alpha Tau Medical vs MBIA

Discover More Opportunities

COMPASS DIVERSIFIED

Compass Diversified Holdings is engaged in owning and managing a diverse set of defensible, middle-market businesses across the branded consumer, industrial, healthcare, and critical outsourced services sectors. The Company categorizes its businesses into two separate groups: branded consumer businesses and industrial businesses. It operates through eight segments: 5.11 Acquisition Corp. (5.11), Boa Holdings Inc. (BOA), Relentless Topco, Inc. (PrimaLoft), THP Topco, Inc. (The Honey Pot Co. or THP), CBCP Products, LLC (Velocity Outdoor or Velocity), AMTAC Holdings, LLC (Arnold), FFI Compass, Inc. (Altor Solutions or Altor). 5.11 is a provider of purpose-built technical apparel and gear for law enforcement, firefighters, EMS, and military special operations as well as outdoor and adventure enthusiasts. PrimaLoft is a provider of branded, high-performance synthetic insulation and materials used primarily in consumer outerwear, and accessories.

ARES ACQUISITION CORPORATION III

Ares Acquisition Corp is a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination.

CANNAE HOLDINGS INC

Operates and invests in public and private companies.